India's pharma exports to the US are expected to stay muted amid pricing pressure, policy uncertainty, and inventory correction in generics, with experts flagging structural shifts in demand and tighter procurement patterns.
For many couples, the experience of a dream baby comes with lots of queries and concerns. It is common knowledge that fertility treatment is an established procedure that is the same for each individual.
.jpeg)
NPPA revises ceiling price of Pfizer’s benzathine benzylpenicillin injection to Rs 13.42 per vial after DoP review, correcting pricing inputs under DPCO guidelines in India.
The Delhi High Court allowing Intas to sell cancer drug Bevatas has emerged as a significant development in India’s pharmaceutical sector, after the court overturned an earlier order that had favoured Sun Pharma in a trademark dispute.
.jpeg)
India–Oman CEPA to boost pharma exports with zero-duty access, faster approvals, and reduced compliance, unlocking growth opportunities in Oman’s pharma market.
As India and the United States begin a fresh round of trade negotiations in New Delhi from June 1 to June 4, the pharmaceutical sector has emerged as one of the most closely watched areas of discussion. The talks are expected to focus on tarif...
Zydus Lifesciences gains US FDA priority review for saroglitazar in PBC, strengthening its specialty pipeline amid rising global demand for liver disease therapies.
Cipla targets 50 global filings, focusing on innovation, biosimilars, and complex generics to expand US and Europe presence and strengthen chronic therapy leadership.
India clears Wockhardt’s Zaynich, a novel antibiotic for drug-resistant infections, backed by strong Phase 3 data, offering an effective treatment option for complicated UTIs and severe Gram-negative cases.
P&G Health stock surges 18% after strong Q4 results with 56% profit growth and margin expansion, driven by brand strength, supply chain efficiency, and steady demand outlook.
, CDSCO.jpg)